BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23257051)

  • 1. [The molecular mechanism of Cr (VI)-induced carcinogenesis].
    Wu G
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Nov; 30(11):878-80. PubMed ID: 23257051
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000.
    Dayan AD; Paine AJ
    Hum Exp Toxicol; 2001 Sep; 20(9):439-51. PubMed ID: 11776406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of chromium(VI) and its relationship to carcinogenesis.
    Shi X; Chiu A; Chen CT; Halliwell B; Castranova V; Vallyathan V
    J Toxicol Environ Health B Crit Rev; 1999; 2(1):87-104. PubMed ID: 10081526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium hexavalent compounds.
    Rep Carcinog; 2004; 11():III63-6. PubMed ID: 21089834
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the effects of chromium complexes].
    Shi L
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):410-2. PubMed ID: 14535115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease.
    O'Brien TJ; Jiang G; Chun G; Mandel HG; Westphal CS; Kahen K; Montaser A; States JC; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):85-92. PubMed ID: 16890479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Green tea and its role on chemoprevention in vivo of genotoxic damage induced by carcinogenic metals (chromium [VI])].
    García-Rodríguez MC; Vilches-Larrea RE; Nicolás-Méndez T; Altamirano-Lozano MA
    Nutr Hosp; 2012; 27(4):1204-12. PubMed ID: 23165563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity of hexavalent chromium.
    Holmes AL; Wise SS; Wise JP
    Indian J Med Res; 2008 Oct; 128(4):353-72. PubMed ID: 19106434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI)-induced toxicity.
    Vasant C; Balamurugan K; Rajaram R; Ramasami T
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1354-60. PubMed ID: 11478807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeability, cytotoxicity, and genotoxicity of chromium (V) and chromium (VI) complexes in V79 Chinese hamster lung cells.
    Dillon CT; Lay PA; Bonin AM; Cholewa M; Legge GJ; Collins TJ; Kostka KL
    Chem Res Toxicol; 1998 Feb; 11(2):119-29. PubMed ID: 9511903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramolecular conversion of pentaaquahydroperoxidochromium(III) ion to aqueous chromium(V): potential source of carcinogenic forms of chromium in aerobic organisms.
    Carraher JM; Bakac A
    Chem Res Toxicol; 2010 Nov; 23(11):1735-42. PubMed ID: 20799728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure determination and respirator selection under the OSHA Hexavalent Chromium Standards.
    Puncochar P
    Occup Health Saf; 2006 Oct; 75(10):134-9. PubMed ID: 17059065
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of chromium(III and VI) on spring barley and maize biomass yield and content of nitrogenous compounds.
    Wyszkowski M; Radziemska M
    J Toxicol Environ Health A; 2010; 73(17-18):1274-82. PubMed ID: 20706953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis.
    Chen QY; Murphy A; Sun H; Costa M
    Toxicol Appl Pharmacol; 2019 Aug; 377():114636. PubMed ID: 31228494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen.
    Dillon CT; Lay PA; Kennedy BJ; Stampfl AP; Cai Z; Ilinski P; Rodrigues W; Legnini DG; Lai B; Maser J
    J Biol Inorg Chem; 2002 Jun; 7(6):640-5. PubMed ID: 12072970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic oxidation of chromium(III): does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)?
    Mulyani I; Levina A; Lay PA
    Angew Chem Int Ed Engl; 2004 Aug; 43(34):4504-7. PubMed ID: 15340954
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenic and carcinogenic actions of chromium and its compounds.
    Mamyrbaev AA; Dzharkenov TA; Imangazina ZA; Satybaldieva UA
    Environ Health Prev Med; 2015 May; 20(3):159-67. PubMed ID: 25877777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity.
    Liu KJ; Shi X; Dalal NS
    Biochem Biophys Res Commun; 1997 Jun; 235(1):54-8. PubMed ID: 9196034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.